Universal Technical Institute, Inc. (UTI) P/E Ratio History
Fairly ValuedTrading at 32.5x, near 5Y avg of 35.3x · 60th percentile · In line with own history · Data 2004–2026
Loading P/E history...
P/E Ratio Analysis
As of November 8, 2026, Universal Technical Institute, Inc. (UTI) trades at a price-to-earnings ratio of 32.5x, with a stock price of $19.93 and trailing twelve-month earnings per share of $0.61.
The current P/E is roughly in line with its 5-year average of 35.3x. Over the past five years, UTI's P/E has ranged from a low of 10.3x to a high of 85.9x, placing the current valuation at the 60th percentile of its historical range.
Compared to the Consumer Defensive sector median P/E of 18.4x, UTI trades at a 77% premium to its sector peers. The sector includes 134 companies with P/E ratios ranging from 0.1x to 147.6x.
The PEG ratio of 0.39 (P/E divided by 51% EPS growth) suggests the stock may be undervalued relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, UTI commands a significant premium over the S&P 500 median P/E of 21.8x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our UTI DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
UTI Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
UTI P/E vs Peers
Colleges & Career Schools peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 9.4Lowest | 1.37Best | +11% | |
| $4B | 31.5 | 2.09 | +27% | |
| $5B | 10.4 | 3.83 | -59% | |
| $1B | 114.8 | 15.24 | +16% | |
| $560M | 24.3 | - | +103% | |
| $684M | 15.4 | 9.03 | +147%Best | |
| $5B | 11.9 | - | -2% | |
| $17B | 547.2 | - | -93% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
UTI Historical P/E Data (2004–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q3 | - | $42.77 | $0.62 | 69.2x | +45% |
| FY2026 Q2 | - | $36.10 | $0.77 | 47.0x | -2% |
| FY2026 Q1 | Dec 31 2025 | $26.13 | $0.97 | 26.9x | -44% |
| FY2025 Q4 | - | $32.55 | $1.14 | 28.6x | -40% |
| FY2025 Q3 | Jun 30 2025 | $33.89 | $1.14 | 29.7x | -38% |
| FY2025 Q2 | Mar 31 2025 | $25.68 | $1.04 | 24.7x | -48% |
| FY2025 Q1 | - | $25.71 | $0.97 | 26.5x | -45% |
| FY2024 Q4 | Sep 30 2024 | $16.26 | $0.74 | 22.0x | -54% |
| FY2024 Q3 | Jun 30 2024 | $15.73 | $0.50 | 31.6x | -34% |
| FY2024 Q2 | Mar 31 2024 | $15.94 | $0.39 | 40.6x | -15% |
| FY2024 Q1 | Dec 31 2023 | $12.52 | $0.29 | 42.7x | -11% |
| FY2023 Q4 | Sep 30 2023 | $8.38 | $0.15 | 56.6x | +18% |
| FY2023 Q3 | Jun 30 2023 | $6.91 | $0.08 | 85.9x | +80% |
| FY2023 Q2 | Mar 31 2023 | $7.38 | $0.12 | 61.2x | +28% |
| FY2023 Q1 | Dec 31 2022 | $6.72 | $0.30 | 22.4x | -53% |
| FY2022 Q4 | Sep 30 2022 | $5.44 | $0.53 | 10.4x | -78% |
| FY2022 Q3 | - | $7.13 | $0.70 | 10.3x | -79% |
| FY2022 Q2 | - | $8.85 | $0.70 | 12.6x | -74% |
| FY2022 Q1 | Dec 31 2021 | $7.82 | $0.43 | 18.1x | -62% |
| FY2021 Q4 | - | $6.76 | $0.17 | 39.1x | -18% |
| FY2021 Q3 | Jun 30 2021 | $6.49 | $0.06 | 103.3x | +116% |
| FY2020 Q2 | - | $5.95 | $0.33 | 18.3x | -62% |
| FY2015 Q3 | - | $8.60 | $0.08 | 107.5x | +125% |
| FY2015 Q2 | - | $9.60 | $0.21 | 45.7x | -4% |
| FY2015 Q1 | Dec 31 2014 | $9.84 | $0.13 | 76.3x | +60% |
| FY2014 Q4 | - | $9.35 | $0.08 | 118.4x | +147% |
| FY2014 Q3 | Jun 30 2014 | $12.14 | $0.06 | 205.8x | +330% |
| FY2014 Q2 | Mar 31 2014 | $12.95 | $0.06 | 219.5x | +359% |
| FY2014 Q1 | - | $13.91 | $0.08 | 169.0x | +253% |
| FY2013 Q4 | Sep 30 2013 | $12.13 | $0.15 | 79.6x | +67% |
| FY2013 Q3 | Jun 30 2013 | $10.33 | $0.17 | 60.0x | +25% |
| FY2013 Q2 | Mar 31 2013 | $12.63 | $0.20 | 62.4x | +31% |
| FY2013 Q1 | Dec 31 2012 | $10.04 | $0.32 | 31.4x | -34% |
| FY2012 Q4 | Sep 30 2012 | $13.70 | $0.34 | 40.3x | -16% |
| FY2012 Q3 | Jun 30 2012 | $13.51 | $0.52 | 26.0x | -46% |
| FY2012 Q2 | Mar 31 2012 | $13.19 | $0.64 | 20.6x | -57% |
| FY2012 Q1 | Dec 31 2011 | $12.78 | $0.84 | 15.2x | -68% |
| FY2011 Q4 | Sep 30 2011 | $13.59 | $1.10 | 12.4x | -74% |
| FY2011 Q3 | - | $19.77 | $1.15 | 17.2x | -64% |
| FY2011 Q2 | - | $19.45 | $1.24 | 15.7x | -67% |
| FY2011 Q1 | Dec 31 2010 | $22.02 | $1.21 | 18.2x | -62% |
| FY2010 Q4 | - | $19.55 | $1.17 | 16.7x | -65% |
| FY2010 Q3 | Jun 30 2010 | $23.64 | $1.19 | 19.9x | -58% |
| FY2010 Q2 | Mar 31 2010 | $22.82 | $1.02 | 22.4x | -53% |
| FY2010 Q1 | - | $20.20 | $0.77 | 26.3x | -45% |
| FY2009 Q4 | Sep 30 2009 | $19.70 | $0.48 | 41.3x | -14% |
| FY2009 Q3 | - | $14.93 | $0.19 | 79.1x | +65% |
| FY2009 Q2 | - | $12.00 | $0.08 | 150.4x | +214% |
| FY2009 Q1 | Dec 31 2008 | $17.17 | $0.15 | 112.1x | +135% |
| FY2008 Q4 | - | $17.06 | $0.30 | 56.3x | +18% |
| FY2008 Q3 | Jun 30 2008 | $12.46 | $0.23 | 53.5x | +12% |
| FY2008 Q2 | Mar 31 2008 | $11.73 | $0.40 | 29.2x | -39% |
| FY2008 Q1 | Dec 31 2007 | $17.00 | $0.55 | 30.8x | -36% |
| FY2007 Q4 | Sep 30 2007 | $18.00 | $0.57 | 31.5x | -34% |
| FY2007 Q3 | Jun 30 2007 | $25.39 | $0.78 | 32.6x | -32% |
| FY2007 Q2 | Mar 31 2007 | $23.08 | $0.80 | 28.9x | -40% |
| FY2007 Q1 | Dec 31 2006 | $22.21 | $0.87 | 25.5x | -47% |
| FY2006 Q4 | Sep 30 2006 | $17.89 | $0.97 | 18.4x | -61% |
| FY2006 Q3 | Jun 30 2006 | $22.02 | $1.13 | 19.5x | -59% |
| FY2006 Q2 | Mar 31 2006 | $30.10 | $1.24 | 24.3x | -49% |
| FY2006 Q1 | Dec 31 2005 | $30.94 | $1.27 | 24.4x | -49% |
| FY2005 Q4 | Sep 30 2005 | $35.61 | $1.26 | 28.3x | -41% |
| FY2005 Q3 | - | $33.20 | $1.17 | 28.4x | -41% |
| FY2005 Q2 | - | $36.80 | $1.13 | 32.6x | -32% |
| FY2005 Q1 | Dec 31 2004 | $38.12 | $1.09 | 35.0x | -27% |
| FY2004 Q4 | - | $30.18 | $1.04 | 29.0x | -39% |
| FY2004 Q3 | Jun 30 2004 | $39.97 | $1.02 | 39.2x | -18% |
Average P/E for displayed period: 47.8x
UTI Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
22+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
UTI — Frequently Asked Questions
Quick answers to the most common questions about buying UTI stock.
What is UTI's P/E ratio?
Universal Technical Institute, Inc. (UTI) trailing twelve-month P/E ratio is 32.5x, based on TTM diluted EPS of $0.61. The 5-year average P/E is 35.3x and the historical range spans 10.3x to 85.9x.
Is UTI stock overvalued or undervalued?
UTI trades at 32.5x P/E, near its 5-year average of 35.3x. The 60th percentile ranking within the 10.3x–85.9x historical range places valuation within normal bounds.
Is UTI stock expensive?
UTI is fairly valued relative to its own history. The current P/E of 32.5x is near the 5-year average of 35.3x (60th percentile of historical range).
What is UTI's historical P/E range?
Over the past 5 years, UTI's P/E ratio has ranged from 10.3x to 85.9x, with a median of 29.7x and an average of 35.3x. The current P/E of 32.5x places the stock at the 60th percentile of this range. Full historical data spans 2004–2026.
How does UTI's P/E compare to the S&P 500?
UTI trades at 32.5x P/E versus the S&P 500 median of 21.8x. The 49% premium to the market typically reflects higher expected earnings growth or quality.
How does UTI's valuation compare to Consumer Defensive peers?
Universal Technical Institute, Inc. P/E of 32.5x compares to the Consumer Defensive sector median of 18.4x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is UTI's PEG ratio?
UTI PEG ratio is 0.39, based on a P/E of 32.5x and EPS growth of 50.7%. A PEG below 1.0 indicates the valuation is supported by the earnings growth rate — typically considered attractive.
What is UTI's earnings yield?
UTI earnings yield is 3.08%, the inverse of its 32.5x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.